Table 5.

Changes in frequency of patients with lipid derangements over 9 months.

ART history
	ART naïve	ART experienced	Total	P ∗∗
Change in frequency of patients with elevated TC over nine months	−4.4%, P ∗ = 1.000	−23.5%, P ∗ = 0.281	−16.9%, P ∗ = 0.2288	0.002
Change in frequency of patients with depressed HDL over 9 months	−34.8%, P ∗ = 1.000	−5.4%, P ∗ < 0.001	−9.3%, P ∗ < 0.001	<0.001
Change in frequency of patients with elevated LDL over 9 months	+13.1%, P ∗ = 1.000	−2.6%, P ∗ < 0.001	−0.6%, P ∗ < 0.001	0.092
Change in frequency of patients with elevated TC/HDL ratio over 9 months	−17.4%, P ∗ = 0.688	−12.1%, P ∗ = 1.000	−12.7%, P ∗ = 0.7552	0.143
Change in frequency of patients with dyslipidemia over 9 months	−21.7%, P ∗ = 0.064	−14.2%, P ∗ < 0.001	−15.2%, P ∗ < 0.001	0.286

Note: SD: standard deviation; level of significance is set at P < 0.05; ^∗ P from McNemar chi square tests for paired data by time of visit; ^∗∗ P from McNemar chi square tests for paired data by ART groups; cutoff values according to NCEP guidelines [20]: elevated TC > 5.2 mmol/L, depressed HDL < 1.1 mmol/L, elevated LDL > 3.2 mmol/L, and elevated TC/HDL ratio > 4.5.